The president’s tariff announcements suggest he has not backed away from his initial strategy, where even minor trading partners will face tariffs.
Related Posts
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Trump’s Tariff Threat for Drug imports Poses Big Political Risks
Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
How Trump Is Gutting Regulatory Agencies Like the SEC, CFPB and EEOC
The furious pace of deregulation is gutting agencies intended to protect ordinary Americans, consumer advocates say. But business groups have long favored regulatory relief.